Table 3.
Treatment | Percent of Patients Receiving Each Treatment (N = 193) |
---|---|
1. Aripiprazole | 18.1 |
2. Olanzapine | 1.0 |
3. Quetiapine | 10.4 |
4. Mirtazapine | 8.8 |
5. Fluoxetine | 8.8 |
6. Paroxetine | 3.1 |
7. Citalopram | 23.3 |
8. Escitalopram | 6.7 |
9. Sertraline | 12.4 |
10. Duloxetine | 3.6 |
11. Venlafaxine | 5.2 |
12. Desvenlafaxine | 1.6 |
13. Bupropion | 10.9 |
14. Psychotherapy | 75.1 |
Note. Data is shown for the N = 193 patients who enrolled in the predictive validity study and attended at least one treatment session. Some patients received multiple treatments in succession and/or simultaneously.